Promoting epithelial-to-mesenchymal transition by D-kynurenine via activating aryl hydrocarbon receptor.

Abstract

Epithelial-to-mesenchymal transition (EMT) is believed to play key roles in the process of cancer metastasis. The molecular changes during EMT are characterized by the down-regulation of epithelial proteins, such as E-cadherin, and the up-regulation of mesenchymal proteins, such as vimentin (VIM). It has been demonstrated that L-kynurenine (L-Kyn), a physiological ligand of Aryl hydrocarbon receptor (Ahr), promotes cancer cells to metastasize. However, the effects of D-enantiomer of kynurenine, D-kynurenine (D-Kyn), on metastasis are still unclear. In the present paper, we firstly confirmed that D-Kyn (10, 40, 60, and 100µM) positively regulated the metastasis of 95D cells, a lung cancer cell line, which was reduced upon siRNAAhr treatment. Moreover, significant enhancement VIM expression was detected in the presence of D-Kyn (10 and 40µM). In contrast, 10µM D-Kyn markedly attenuated E-cadherin level. Additionally, 10µM D-Kyn-mediated changes of VIM and E-cadherin were substantially attenuated on siRNAAhr treatment as well. Most importantly, the evidences-10/40µM D-Kyn-induced up-regulation of CYP1A1, 10µM D-Kyn-induced increase of nuclear transfer of Ahr, and 10/40/60/100µM D-Kyn-induced enhancement of DER-luciferase activity-indicated that D-Kyn was capable of activating Ahr in fact. These results suggest that D-Kyn increases lung cancer cells to metastasize by activating Ahr.